Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WINTON GROUP Ltd lessened its stake in Penumbra, Inc. (NYSE:PEN – Free Report) by 44.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,231 shares of the company’s stock after selling 1,755 shares during the period. WINTON GROUP Ltd’s holdings in Penumbra […]
Penumbra, Inc. (NYSE:PEN – Get Free Report) Director Bridget O’rourke sold 150 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $226.41, for a total transaction of $33,961.50. Following the sale, the director now owns 4,214 shares of the company’s stock, valued at […]
Boulder Hill Capital Management LP acquired a new stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 800 shares of the company’s stock, valued at approximately $275,000. Other institutional investors and hedge funds have also […]
Rhumbline Advisers boosted its holdings in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 3.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 117,764 shares of the company’s stock after buying an additional 4,164 shares during the quarter. Rhumbline […]
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twelve analysts that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month price target […]